www.klinickafarmakologie.cz / Klin Farmakol Farm. 2024;38(1):15-21 / KLINICKÁ FARMAKOLOGIE A FARMACIE 21 HLAVNÍ TÉMA Medication adherence – the way to understand patients 29. Giardini A, Martin MT, Cahir C, et al. Toward appropriate criteria in medication adherence assessment in older persons: Position Paper. Aging Clin Exp Res. 2016;28(3):371-381. 30. Dima AL, Dediu D. Computation of adherence to medication and visualization of medication histories in R with AdhereR: Towards transparent and reproducible use of electronic healthcare data. PLoS One. 2017;12(4). 31. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: Its importance in cardiovascular outcomes. Circulation. 2009;119(23):3028-3035. 32. Kronish IM, Thorpe CT, Voils CI. Measuring the multiple domains of medication nonadherence: Findings from a Delphi survey of adherence experts. Transl Behav Med. 2021;11(1):104-113. 33. Ilardo ML, Speciale A. The community pharmacist: Perceived barriers and patient-centered care communication. Int J Environ Res Public Health. 2020;17(2). 34. Dalton K, Byrne S. Role of the pharmacist in reducing healthcare costs: current insights. Integr Pharm Res Pract. 2017;6:37-46. 35. McLean G, Band R, Saunderson K, et al. Digital interventions to promote self-management in adults with hypertension systematic review and meta-analysis. J Hypertens. 2016;34(4):600-612. 36. Meddings J, Kerr EA, Heisler M, et al. Physician assessments of medication adherence and decisions to intensify medications for patients with uncontrolled blood pressure: Still no better than a coin toss. BMC Health Serv Res. 2012;12(1). 37. Weir MR, Maibach EW, Bakris GL, et al. Implications of a health lifestyle and medication analysis for improving hypertension control. Arch Intern Med. 2000;160(4):481-490. 38. Dietrich F, Zeller A, Haag M, et al. Communicating electronic adherence data to physicians – consensus-based development of a compact reporting form. Int J Environ Res Public Health. 2021;18(19). 39. Lerner BH. From careless consumptives to recalcitrant patients: the historical construction of noncompliance. Soc Sci Med. 1997;45(9):1423-1431. 40. Rafii F, Fatemi NS, Danielson E, et al. Compliance to treatment in patients with chronic illness: A concept exploration. Iran J Nurs Midwifery Res. 2014;19(2):159-167. 41. Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691-705. 42. Sabate E. World Health Organization. Adherence to LongTerm Therapies: Evidence for Action. World Health Organization; 2003. 43. De Geest S, Zullig LL, Dunbar-Jacob J, et al. ESPACOMP medication adherence reporting guideline (EMERGE). Ann Intern Med. 2018;169(1):30-35. 44. Martin LR, Williams SL, Haskard KB, et al. The challenge of patient adherence. Ther Clin Risk Manag. 2005;1(3):189-199. 45. Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304-314. 46. Arnet I, Haefeli WE. Compliance: Fakten Perspektiven. Managed Care. 1998;3:27-31. 47. Penna R, Knowlton C. The need for pharmaceutical care. In: Pharmaceutical Care. Taylor & Francis; 1998:225-226. 48. Fallsberg M. Reflection on Medicines and Medication - a Qualitative Analysis among People on Long-Term Drug Regimens. Linkoping University; 1991. 49. Rimer B, & GB. How Do Persuasive Health Messages Work? A Health Education Field Study. Health Educ Q. 1984;11(3): 313-321. 50. Hatoum HT, HRA, & LBL. OBRA 90: Patient counseling-enhancing patient outcomes. US pharmacist. 1993;18(1):75-86. 51. Boeni F, Hersberger KE, Arnet I. Multidrug punch cards in primary care: A mixed methods study on patients’ preferences and impact on adherence. Front Pharmacol. 2014;5(SEP). 52. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting. JAMA. 2003;289(9):1107-1116. 53. Vermeire E, Hearnshaw H, Van Royen P, et al. Patient adherence to treatment: Three decades of research. A comprehensive review. J Clin Pharm Ther. 2001;26(5):331-342. 54. Col N FJKP. The Role of Medication Noncompliance and Adverse Drug Reactions in Hospitalizations of the Elderly. Arch Intern Med. 1990;150(4):841-845. 55. Bae SG, Kam S, Park KS, et al. Factors related to intentional and unintentional medication nonadherence in elderly patients with hypertension in rural community. Patient Prefer Adherence. 2016;10:1979-1989. 56. Dalli LL, Kilkenny MF, Arnet I, et al. Towards better reporting of the proportion of days covered method in cardiovascular medication adherence: A scoping review and new tool TEN-SPIDERS. Br J Clin Pharmacol. 2022;88(10):4427-4442. 57. Wawruch M, Wimmer G, Murin J, et al. Non-adherence to statin treatment in older patients with peripheral arterial disease depending on persistence status. Biomedicines. 2020;8(10):1-12. 58. Wawruch M, Petrova M, Tesar T, et al. Factors associated with non-adherence to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in older patients with peripheral arterial disease. Front Pharmacol. 2023;14. 59. Kozma C, Dickson, Phillips, Meletiche. Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis. Patient Prefer Adherence. [Internet] 2013;509 [cited 2023 Dec 10]. 60. Bruthans J, Berger J, Šoltés J, et al. Using the national electronic prescription system to determine the primary non-adherence to medication in the Czech Republic. Front Pharmacol. 2023;14. 61. Bauer AM, Schillinger D, Parker MM, et al. Health literacy and antidepressant medication adherence among adults with diabetes: The diabetes study of Northern California (DISTANCE). J Gen Intern Med. 2013;28(9):1181-1187. 62. Fernández A, Quan J, Moffet H, et al. Adherence to newly prescribed diabetes medications among insured Latino and white patients with diabetes. JAMA Intern Med. 2017;177(3):371-379. 63. Williams JLS, Walker RJ, Smalls BL, et al. Effective interventions to improve medication adherence in Type 2 diabetes: a systematic review. Diabetes Management. 2014;4(1):29-48. 64. Arnet I, Sahm LJ, Gregório J, et al. Development and validation of the 15-STARS - A novel self-report pharmacy-based questionnaire to screen for medication non-adherence. Res Social Adm Pharm. 2023:S1551-7411(23)00487-4. 65. Mokkink LB, Prinsen C, Patrick D, et al. COSMIN methodology for systematic reviews of Patient-Reported Outcome Measures (PROMs) – user manual. [Internet] 2018. [cited 2023 Dec 10]Available at: https://cosminnl/wp-content/uploads/COSMIN-syst-review-for-PROMs-manual_version-1_feb-2018pdf. 66. Arnet I, Caloz S, Eickhoff C, et al. Psychometric Quality of Questionnaires on Medication Adherence – a Secondary Analysis. Live paper presentation at the 27th Annual Conference of ESPACOMP. Budapest, 2. 12. 2023. 67. Gregoriano C, Dieterle T, Breitenstein AL, et al. Does a tailored intervention to promote adherence in patients with chronic lung disease affect exacerbations? A randomized controlled trial. Respir Res. 2019;20(1). 68. Torres-Robles A, Wiecek E, Tonin FS, et al. Comparison of interventions to improve long-term medication adherence across different clinical conditions: A systematic review with network meta-analysis. Front Pharmacol. 2018;9. 69. Mills EJ, Lester R, Thorlund K, et al. Interventions to promote adherence to antiretroviral therapy in Africa: A network meta-analysis. Lancet HIV. 2014;1(3):104-111. 70. Van Driel ML, Morledge MD, Ulep R, et al. Interventions to improve adherence to lipid-lowering medication. Cochrane Database of Systematic Reviews. 2016;2016(12). 71. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836-1841. 72. Dietrich FM, Hersberger KE, Arnet I. Benefits of medication charts provided at transitions of care: A narrative systematic review. BMJ Open. 2020;10(10). 73. Marquis J, Schneider MP, Payot V, et al. Swallowing difficulties with oral drugs among polypharmacy patients attending community pharmacies. Int J Clin Pharm. 2013;35(6):1130-1136. 74. Berkhout C, Berbra O, Favre J, et al. Defining and evaluating the Hawthorne effect in primary care, a systematic review and meta-analysis. Front Med (Lausanne). 2022;9. 75. Haskard Zolnierek KB, Dimatteo MR. Physician communication and patient adherence to treatment: A meta-analysis. Med Care. 2009;47(8):826-834. 76. Hepler CD, SLM. Opportunities and responsibilities in pharmaceutical care. Am J Pharm Ed. 1990;53:75-155. 77. Boeni F, Arnet I, Hersberger KE. Adherence counseling during patient contacts in Swiss community pharmacies. Patient Prefer Adherence. 2015;9:597-605. 78. Cipolle RJ, SLM and MPC. Pharmaceutical Care Practice. Health Professions Division; 1998.
RkJQdWJsaXNoZXIy NDA4Mjc=